Clinical Trial Update: A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

View source ↗

Summary

A clinical trial is evaluating canakinumab for Familial Mediterranean Fever and Still's disease (including systemic juvenile idiopathic arthritis and adult-onse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Still Disease
• Familial Mediterranean Fever
• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• ILARIS (canakinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Familial Mediterranean Fever, Still Disease | Status: NOT_YET_RECRUITING